Stocks on the move
Real-time equity news
U.S. stock market report
0838 EST 15March2010
Garmin shares worth a closer look: Barron's
Garmin Ltd, the No 1 U.S. navigation device maker, may be worth a closer look by investors, according to Barron's.
Only three analysts out of 19 rate the company's shares a buy, the weekly business newspaper said in its March 15 edition, noting the stock had been hit hard after the company's past two earnings releases.
But 'earnings projections are rising and disciplined value-fund managers are discovering the name,' Barron's said.
For details, see
Shares of Garmin closed Friday at $35.91.
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0831 EST 15March2010
NY manufacturing growth slows in March: survey
A gauge of manufacturing in New York state fell by less than forecast in March as employment in the sector rose to its highest since October 2007, the New York Federal Reserve said in a report on Monday.
The New York Fed's 'Empire State' general business conditions index dropped to 22.86 this month from 24.91 in February.
Economists polled by Reuters had expected a reading of 22.00 for March.
For details, see
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0828 EST 15March2010
Boston Scientific drops after analyst comment
Shares of Boston Scientific Corp fell in premarket trading on Monday, after an analyst at Bernstein Research said the company was indefinitely suspending all sales of its implantable cardioverter defibrillator devices.
The move comes as a result of a documentation error in its regulatory filings, the analyst said.
For details, see
The stock dropped 13 percent to $6.75 before the bell.
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0824 EST 15March2010
Barron's sees upside for Dr Pepper Snapple
A lot more sizzle could be injected into shares of Dr Pepper Snapple Group , despite a 150-percent rise of the stock in the past year, according to Barron's.
'The company has some large, underappreciated opportunities for expansion,' the business weekly newspaper said in its March 15 edition.
'As the market awakens to the potential, the stock could rise a further 25 percent or so, to more than $40,' Barron's said.
For details, see
Shares of Dr Pepper closed Friday at $34.97.
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0819 EST 15March2010
Toyota to cut Prius output as sales slow: source
Toyota Motor Corp is slashing its output of the Prius hybrid model by 10 percent starting this month due to a slowdown in sales from a peak last year, a source at a group company told Reuters on Monday.
The automaker had been building a combined 50,000 Priuses a month at two Japanese factories since the third-generation model debuted last May.
For details, see
U.S.-listed shares of Toyota closed Friday at $76.99.
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net Keywords: MARKETS STOCKSNEWS
COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
Real-time equity news
U.S. stock market report
0838 EST 15March2010
Garmin shares worth a closer look: Barron's
Garmin Ltd, the No 1 U.S. navigation device maker, may be worth a closer look by investors, according to Barron's.
Only three analysts out of 19 rate the company's shares a buy, the weekly business newspaper said in its March 15 edition, noting the stock had been hit hard after the company's past two earnings releases.
But 'earnings projections are rising and disciplined value-fund managers are discovering the name,' Barron's said.
For details, see
Shares of Garmin closed Friday at $35.91.
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0831 EST 15March2010
NY manufacturing growth slows in March: survey
A gauge of manufacturing in New York state fell by less than forecast in March as employment in the sector rose to its highest since October 2007, the New York Federal Reserve said in a report on Monday.
The New York Fed's 'Empire State' general business conditions index dropped to 22.86 this month from 24.91 in February.
Economists polled by Reuters had expected a reading of 22.00 for March.
For details, see
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0828 EST 15March2010
Boston Scientific drops after analyst comment
Shares of Boston Scientific Corp fell in premarket trading on Monday, after an analyst at Bernstein Research said the company was indefinitely suspending all sales of its implantable cardioverter defibrillator devices.
The move comes as a result of a documentation error in its regulatory filings, the analyst said.
For details, see
The stock dropped 13 percent to $6.75 before the bell.
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0824 EST 15March2010
Barron's sees upside for Dr Pepper Snapple
A lot more sizzle could be injected into shares of Dr Pepper Snapple Group , despite a 150-percent rise of the stock in the past year, according to Barron's.
'The company has some large, underappreciated opportunities for expansion,' the business weekly newspaper said in its March 15 edition.
'As the market awakens to the potential, the stock could rise a further 25 percent or so, to more than $40,' Barron's said.
For details, see
Shares of Dr Pepper closed Friday at $34.97.
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
0819 EST 15March2010
Toyota to cut Prius output as sales slow: source
Toyota Motor Corp is slashing its output of the Prius hybrid model by 10 percent starting this month due to a slowdown in sales from a peak last year, a source at a group company told Reuters on Monday.
The automaker had been building a combined 50,000 Priuses a month at two Japanese factories since the third-generation model debuted last May.
For details, see
U.S.-listed shares of Toyota closed Friday at $76.99.
Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net Keywords: MARKETS STOCKSNEWS
COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
